Profiling Protein Arginine Deiminase 4 (PAD4): A novel screen to identify PAD4 inhibitors

Profiling Protein Arginine Deiminase 4 (PAD4): A novel screen to identify PAD4 inhibitors Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors The Development of N-α-(2-Carboxyl)benzoyl-N⁵-(2-fluoro-1-iminoethyl)-<scp>l</scp>-ornithine Amide (o-F-amidine) and N-α-(2-Carboxyl)benzoyl-N⁵-(2-chloro-1-iminoethyl)-<scp>l</scp>-ornithine Amide (o-Cl-amidine) As Second Generation Protein Arginine Deiminase (PAD) Inhibitors Peptidylarginine deiminases 4 as a promising target in drug discovery Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation Rhodanine derivatives as novel inhibitors of PDE4 Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): Identification of phenmedipham and amperozide as FAAH inhibitors Thalidomide analogs and PDE4 inhibition A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis